Annual Total Liabilities
$397.26 M
+$175.34 M+79.01%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual total liabilities is $397.26 million, with the most recent change of +$175.34 million (+79.01%) on December 31, 2023.
- During the last 3 years, AXSM annual total liabilities has risen by +$324.92 million (+449.14%).
- AXSM annual total liabilities is now at all-time high.
Performance
AXSM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$468.56 M
+$23.19 M+5.21%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly total liabilities is $468.56 million, with the most recent change of +$23.19 million (+5.21%) on September 30, 2024.
- Over the past year, AXSM quarterly total liabilities has increased by +$71.30 million (+17.95%).
- AXSM quarterly total liabilities is now at all-time high.
Performance
AXSM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AXSM Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.0% | +17.9% |
| 3 y3 years | +449.1% | +534.2% |
| 5 y5 years | +2650.8% | +1145.6% |
AXSM Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +450.6% | at high | +549.4% |
| 5 y | 5-year | at high | +849.8% | at high | +1175.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Axsome Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $468.56 M(+5.2%) |
| Jun 2024 | - | $445.37 M(+10.9%) |
| Mar 2024 | - | $401.69 M(+1.1%) |
| Dec 2023 | $397.26 M(+79.0%) | $397.26 M(+19.9%) |
| Sep 2023 | - | $331.35 M(-0.4%) |
| Jun 2023 | - | $332.83 M(+20.0%) |
| Mar 2023 | - | $277.37 M(+25.0%) |
| Dec 2022 | $221.92 M(+207.6%) | $221.92 M(+22.2%) |
| Sep 2022 | - | $181.60 M(+9.8%) |
| Jun 2022 | - | $165.36 M(+123.9%) |
| Mar 2022 | - | $73.86 M(+2.4%) |
| Dec 2021 | $72.15 M(-0.3%) | $72.15 M(-2.3%) |
| Sep 2021 | - | $73.88 M(+2.9%) |
| Jun 2021 | - | $71.83 M(+1.7%) |
| Mar 2021 | - | $70.61 M(-2.4%) |
| Dec 2020 | $72.34 M(+73.0%) | $72.34 M(+5.8%) |
| Sep 2020 | - | $68.37 M(+86.1%) |
| Jun 2020 | - | $36.75 M(-11.8%) |
| Mar 2020 | - | $41.64 M(-0.4%) |
| Dec 2019 | $41.83 M | $41.83 M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $37.62 M(+23.4%) |
| Jun 2019 | - | $30.49 M(+15.0%) |
| Mar 2019 | - | $26.53 M(+83.7%) |
| Dec 2018 | $14.44 M(-23.3%) | $14.44 M(-6.1%) |
| Sep 2018 | - | $15.38 M(+4.5%) |
| Jun 2018 | - | $14.72 M(-4.1%) |
| Mar 2018 | - | $15.35 M(-18.5%) |
| Dec 2017 | $18.84 M(+13.2%) | $18.84 M(+19.4%) |
| Sep 2017 | - | $15.78 M(-3.1%) |
| Jun 2017 | - | $16.29 M(-4.9%) |
| Mar 2017 | - | $17.13 M(+2.9%) |
| Dec 2016 | $16.64 M(+532.3%) | $16.64 M(+147.1%) |
| Sep 2016 | - | $6.74 M(+32.0%) |
| Jun 2016 | - | $5.10 M(+30.4%) |
| Mar 2016 | - | $3.91 M(+48.7%) |
| Dec 2015 | $2.63 M(-56.1%) | $2.63 M(+17.8%) |
| Sep 2015 | - | $2.23 M(-84.1%) |
| Jun 2015 | - | $14.09 M(+135.2%) |
| Dec 2014 | $5.99 M(+45.2%) | $5.99 M |
| Dec 2013 | $4.13 M | - |
FAQ
- What is Axsome Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics annual total liabilities year-on-year change?
- What is Axsome Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly total liabilities year-on-year change?
What is Axsome Therapeutics annual total liabilities?
The current annual total liabilities of AXSM is $397.26 M
What is the all time high annual total liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total liabilities is $397.26 M
What is Axsome Therapeutics annual total liabilities year-on-year change?
Over the past year, AXSM annual total liabilities has changed by +$175.34 M (+79.01%)
What is Axsome Therapeutics quarterly total liabilities?
The current quarterly total liabilities of AXSM is $468.56 M
What is the all time high quarterly total liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total liabilities is $468.56 M
What is Axsome Therapeutics quarterly total liabilities year-on-year change?
Over the past year, AXSM quarterly total liabilities has changed by +$71.30 M (+17.95%)